Drug LitigationRecent Study Links Xarelto Use to Eye Bleeding

July 23, 2015

In the recent June 2015 issue of JAMA Ophthalmology, researchers studied some of Xarelto’s disturbing side effects, further calling into question the safety of the drug. These scientists studied the link between Xarelto usage and the possibility of an increase in stomach bleeds and eye hemorrhaging. Drs. Judy H. Hun and John C. Hwang found that patients in their 70s and 80s who had taken Xarelto after transitioning from warfarin had experience eye bleeding known as vitreous hemorrhages.

Because this particular side effect was linked to patients who had transitioned from warfarin to rivaroxaban (the generic of Xarelto), the doctors warn that other clinicians should be made aware of this potential side effect in their patients. Given that more and more doctors are prescribing Xarelto because it requires less monitoring by doctors themselves. However, given studies like these, doctors should be wary of prescribing Xarelto to patients and closely monitor them for any possible side effects.

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case.

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy